Andy Kuo

16PUBLICATIONS
33CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)PharmacogenomicsMedical bacteriologyBiologically active moleculesBiomaterials
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Aug 10, 2026
An NLRP3 inflammasome inhibitor evoked dose-dependent anti-allodynia in the hindpaws of a rat model of chemotherapy-induced peripheral neuropathy.

|Feb 16, 2026
Preclinical Pharmacokinetics and Pharmacodynamics of Antibiotic Adjuvants.

Viet Tin Pham, David M P De Oliveira, Andy Kuo

|Apr 11, 2025
Florasulam Is a Potent Inhibitor of Mycobacterium tuberculosis Acetohydroxyacid Synthase and Possesses In Vivo Antituberculosis Activity.

Shun Jie Wun, Lendl Tan, Thierry G Lonhienne

|Dec 22, 2023
seco-1-Azacubane-2-carboxylic Acid: Derivative Scope and Comparative Biological Evaluation.

Dehui Kong, Tyler Fahrenhorst-Jones, Andy Kuo

|Mar 01, 2023
Multitargeted Opioid Ligand Discovery as a Strategy to Retain Analgesia and Reduce Opioid-Related Adverse Effects.

Maree T Smith, Dehui Kong, Andy Kuo

|Jan 13, 2023
CYX-5, a G-protein biassed MOP receptor agonist, DOP receptor antagonist and KOP receptor agonist, evokes constipation but not respiratory depression relative to morphine in rats.

Mohammad Zafar Imam, Andy Kuo, Sussan Ghassabian

Pageof 3

Frequent Collaborators

16 joint publications

Maree T Smith

5 joint publications

Mohammad Zafar Imam

4 joint publications

Craig M Williams

3 joint publications

Sussan Ghassabian